learn about perjeta®, a neoadjuvant and metastatic breast cancer treatment for patients with her2-positive breast cancer.what does perjeta treat?perjeta® (pertuzumab) is approved for use in combination with herceptin® (trastuzumab) and docetaxel in people who have her2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-her2 therapy or chemotherapy for metastatic breast cancer.perjeta® (pertuzumab) is approved for use prior to surgery in combination with herceptin® (trastuzumab) and docetaxel in people with her2-positive, locally advanced, inflammatory, or early stage (tumor is greater than 2 cm in diameter or node positive) breast cancer. perjeta should be used as part of a complete treatment regimen for early stage breast cancer. this use of perjeta is based on an improvement in the percentage of patients whose cancer shrinks or disappears after treatment. currently, no data have shown whether or not treatment with perjeta prior to surgery improves survival.• the safety of perjeta in combination with doxorubicin-containing regimens has not been established• the safety of perjeta administered for greater than 6 cycles for early-stage breast cancer has not been established.important safety information• perjeta may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure)• receiving perjeta during pregnancy can result in the death of an unborn baby and birth defects— if you think you may be pregnant, you should contact your healthcare provider immediately— if you are exposed to perjeta during pregnancy, or become pregnant while receiving perjeta or within 7 months following the last dose of perjeta in combination with herceptin, you are encouraged to enroll in the mother pregnancy registry by contacting 1-800-690-6720 or visiting http://www.motherpregnancyregistry.com/ and report perjeta exposure to genentech at 1-88
Floodlight is an optional feature in DFA that allows advertisers to capture and report on the actions of users who visit their website after viewing or clicking on one of the advertiser's ads. For the implementation of Floodlight, Floodlight tags must be placed on the advertiser's webpages.
Simple, fast, and powerful. Optimizely is a dramatically easier way for you to improve your website through A/B testing. Create an experiment in minutes with our easy-to-use visual interface with absolutely no coding or engineering required. Convert your website visitors into customers and earn more revenue today!
Demandbase is a technology company that enables B2B marketers to improve marketing conversions and turn web traffic into sales. Demandbase's solutions leverage its proprietary Business Resolution Platform, including real-time identification of the formerly anonymous companies visiting a web site, and unique analytics to make cus...
The Apache HTTP Server is an open-source HTTP server for modern operating systems including UNIX, Microsoft Windows, Mac OS/X and Netware. The goal of this project is to provide a secure, efficient and extensible server that provides HTTP services observing the current HTTP standards. Apache has been the most popular web server ...
Allows a website to define how a page is rendered in Internet Explorer 8, allowing a website to decide to use IE7 style rendering over IE8 rendering.
Meta Keywords are a specific type of meta tag that appear in the HTML code of a Web page and help tell search engines what the topic of the page is.
Meta descriptions are HTML attributes that provide concise explanations of the contents of web pages. Meta descriptions are commonly used on search engine result pages (SERPs) to display preview snippets for a given page.
The http-equiv attribute provides an HTTP header for the information/value of the content attribute. The http-equiv attribute can be used to simulate an HTTP response header.